Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,174 | 2,083 | 1,898 | 2,477 | 2,384 |
| Operating Income | -3,174 | -2,083 | -1,898 | -2,477 | -2,384 |
| Other Income | 26 | -1 | 19 | 22 | -1,029 |
| Pre-tax Income | -3,147 | -2,084 | -1,879 | -2,455 | -3,414 |
| Income Tax | 7 | N/A | N/A | 2 | 36 |
| Net Income Continuous | -3,155 | -2,084 | -1,879 | -2,457 | -3,449 |
| Net Income | $-3,155 | $-2,084 | $-1,879 | $-2,457 | $-3,436 |
| EPS Basic Total Ops | -30.16 | -43.10 | -44.66 | -110.56 | -259.18 |
| EPS Basic Continuous Ops | -30.22 | -43.10 | -44.59 | -110.57 | -260.21 |
| EPS Diluted Total Ops | -30.16 | -43.10 | -44.66 | -110.56 | -259.18 |
| EPS Diluted Continuous Ops | -30.22 | -43.10 | -44.59 | -110.57 | -260.21 |
| EPS Diluted Before Non-Recurring Items | N/A | -43.20 | -45.00 | N/A | N/A |
| EBITDA(a) | $-3,091 | $-1,998 | $-1,813 | $-2,392 | $-2,300 |